CTEP

Results: 314



#Item
91CTEP Rapid Communication SOLICITATION FOR LETTERS OF INTENT Clinical trials Preclinical experiments

CTEP Rapid Communication SOLICITATION FOR LETTERS OF INTENT Clinical trials Preclinical experiments

Add to Reading List

Source URL: dctd.cancer.gov

Language: English - Date: 2009-01-24 09:57:10
92Pharmaceutical sciences / Pharmaceutics / Pharmacology / Adverse event / Food and Drug Administration / Clinical trial / Clinical research / Pharmaceutical industry / Research

Phase 2 Combination Template X. ADVERSE EVENTS: LISTS AND REPORTING REQUIREMENTS

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2008-05-28 21:39:37
93National Institutes of Health National Cancer Institute Division of Cancer Treatment and Diagnosis Cancer Therapy Evaluation Program

National Institutes of Health National Cancer Institute Division of Cancer Treatment and Diagnosis Cancer Therapy Evaluation Program

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2008-05-28 21:39:37
94Pharmaceutical sciences / Pharmaceutics / Pharmacology / Adverse event / Food and Drug Administration / Clinical trial / Clinical research / Pharmaceutical industry / Research

Phase 1 Combination Template X. ADVERSE EVENTS: LIST AND REPORTING REQUIREMENTS Adverse event (AE) monitoring and reporting is a routine part of every clinical trial. The following list of AEs (Section X.1) and the ch

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2008-05-28 21:39:37
95MDT CTEP Manual PREFACE The MDT CTEP Manual has been developed to provide guidance to Local Entities in the administration, design and construction of Community Transportation Enhancement Projects

MDT CTEP Manual PREFACE The MDT CTEP Manual has been developed to provide guidance to Local Entities in the administration, design and construction of Community Transportation Enhancement Projects

Add to Reading List

Source URL: mdt.mt.gov

Language: English - Date: 2012-08-10 14:44:18
96CTEP RAPID COMMUNICATION SOLICITATION FOR LETTERS OF INTENT FOR PHASE 1 TRIALS AMINOFLAVONE PRODRUG (AFP-464) NSC[removed]NH2

CTEP RAPID COMMUNICATION SOLICITATION FOR LETTERS OF INTENT FOR PHASE 1 TRIALS AMINOFLAVONE PRODRUG (AFP-464) NSC[removed]NH2

Add to Reading List

Source URL: dctd.cancer.gov

Language: English - Date: 2009-01-24 09:57:10
97SACRAMENTO COUNT Y  CTEP M E A S U R E

SACRAMENTO COUNT Y CTEP M E A S U R E

Add to Reading List

Source URL: www.sacta.org

Language: English - Date: 2009-12-07 18:10:34
98SACRAMENTO COUNT Y  CTEP M E A S U R E

SACRAMENTO COUNT Y CTEP M E A S U R E

Add to Reading List

Source URL: www.sacta.org

Language: English - Date: 2012-02-28 16:52:51
99Oncology / Transfusion medicine / Febrile neutropenia / Neutropenia / Thrombocytopenia / Platelet / Bleeding / Fever / Mucositis / Medicine / Biology / Blood

Attribution Key: Unrelated 1 The adverse event (toxicity) is not related to the investigational agent(s). Page 1 of 3 Unlikely 2 The adverse event (toxicity) is doubtfully related to the investigational agent(s). Revised

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2008-05-28 21:39:37
100Pharmaceutics / Pharmaceutical sciences / Adverse event / Clinical trial / Norfloxacin / Clinical research / Pharmaceutical industry / Research

Phase 2 Single Agent Template X. ADVERSE EVENTS: LIST AND REPORTING REQUIREMENTS Adverse event (AE) monitoring and reporting is a routine part of every clinical trial. The following list of AEs (Section X.1) and the c

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2008-05-28 21:39:37